Merck Historical Balance Sheet


USD 90.60  0.42  0.46%   

Trend analysis of Merck Company balance sheet accounts such as Total Assets of 96.4 B provides information on Merck's total assets, liabilities, and equity, which is the actual value of Merck Company to its prevalent stockholders. By breaking down trends over time using Merck balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Merck Company prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merck Company is a good buy for the upcoming year.
Additionally, see Stocks Correlation.

About Merck Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Merck Company at a specified time, usually calculated after every quarter, six months, or one year. Merck Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Merck and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Merck currently owns. An asset can also be divided into two categories, current and non-current.

Merck Balance Sheet Chart

Merck Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Merck Company uses and utilizes its capital. It also shows what exactly a company owns and owes.
Merck Investments are decreasing as compared to previous years. The last year's value of Investments was reported at 370 Million. The current Investments Current is estimated to increase to about 714.9 M, while Accumulated Other Comprehensive Income is projected to decrease to (4.8 B).

Total Assets

Total assets refers to the total amount of Merck assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Merck Company books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; Tax Assets and Trade and Non Trade Receivables.

Current Assets

Current assets of Merck Company include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Merck. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Merck Company balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Merck books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; [DeferredRev]; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Merck balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Merck Investments are decreasing as compared to previous years. The last year's value of Investments was reported at 370 Million. The current Investments Current is estimated to increase to about 714.9 M, while Accumulated Other Comprehensive Income is projected to decrease to (4.8 B).
 2019 2020 2021 2022 (projected)
Receivables6.78 B7.85 B9.23 B7.96 B
Inventories5.98 B6.31 B5.95 B6.45 B

Merck balance sheet Correlations

Click cells to compare fundamentals

Merck Account Relationship Matchups

Merck balance sheet Accounts

201720182019202020212022 (projected)
Inventories5.1 B5.44 B5.98 B6.31 B5.95 B6.45 B
Receivables6.87 B7.07 B6.78 B7.85 B9.23 B7.96 B
Accounts Payable3.1 B3.32 B3.74 B4.59 B4.61 B3.69 B
Accumulated Other Comprehensive Income(4.91 B)(5.54 B)(6.19 B)(6.63 B)(4.43 B)(4.78 B)
Total Assets87.87 B82.64 B84.4 B91.59 B105.69 B96.37 B
Current Assets24.77 B25.88 B27.48 B27.76 B30.27 B28.67 B
Assets Non Current63.11 B56.76 B56.91 B63.82 B75.43 B67.7 B
Cash and Equivalents6.09 B7.96 B9.68 B8.05 B8.1 B8.28 B
Cash and Equivalents USD6.09 B7.96 B9.68 B8.05 B8.1 B8.28 B
Total Debt24.41 B25.11 B26.35 B31.79 B33.1 B31.98 B
Debt Current3.06 B5.31 B3.61 B6.43 B2.41 B3.24 B
Debt Non Current21.35 B19.81 B22.74 B25.36 B30.69 B28.73 B
Total Debt USD24.41 B25.11 B26.35 B31.79 B33.1 B31.98 B
Shareholders Equity34.34 B26.7 B25.91 B25.32 B38.18 B36.98 B
Shareholders Equity USD34.34 B26.7 B25.91 B25.32 B38.18 B36.98 B
Goodwill and Intangible Assets32.47 B31.36 B33.62 B32.98 B44.2 B38.86 B
Inventory5.1 B5.44 B5.98 B5.55 B5.95 B5.51 B
Investments14.53 B7.13 B2.24 B785 M370 M379.74 M
Investments Current7.83 B2.41 B899 M774 M696.6 M714.93 M
Investments Non Current12.12 B6.23 B1.47 B785 M370 M379.74 M
Total Liabilities53.3 B55.76 B58.4 B66.18 B67.44 B67.84 B
Current Liabilities18.61 B22.21 B22.22 B27.33 B23.87 B24.22 B
Liabilities Non Current34.69 B33.55 B36.18 B38.86 B43.56 B43.62 B
Trade and Non Trade Payables3.1 B3.32 B3.74 B4.33 B4.61 B4.17 B
Property Plant and Equipment Net12.44 B13.29 B15.05 B17 B19.28 B18.67 B
Trade and Non Trade Receivables6.87 B7.07 B6.78 B6.8 B9.23 B9.07 B
Accumulated Retained Earnings Deficit41.35 B42.58 B46.6 B47.36 B53.7 B53.8 B
Tax Liabilities2.93 B3.67 B2.21 B2.6 B4.67 B5.07 B

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Volatility Analysis Now


Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Merck Company using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
230.6 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.